We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+2.04%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$23.3B
AUM Growth
-$265M
Cap. Flow
-$917M
Cap. Flow %
-3.93%
Top 10 Hldgs %
47.97%
Holding
197
New
23
Increased
32
Reduced
40
Closed
30

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$386M
2
AON icon
Aon
AON
+$368M
3
CTLT
CATALENT, INC.
CTLT
+$282M
4
CRM icon
Salesforce
CRM
+$266M
5
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$184M

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$924M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$262M
3
CSGP icon
CoStar Group
CSGP
+$251M
4
INSP icon
Inspire Medical Systems
INSP
+$135M
5
WAB icon
Wabtec
WAB
+$123M

Sector Composition

Rank Sector Weight
1 Healthcare 29.33%
2 Technology 12.47%
3 Financials 9.64%
4 Industrials 5.44%
5 Communication Services 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOG icon
26
Alphabet (Google) Class C
GOOG
$4.18T
$330M 1.41%
1,796,540
-1,541,410
-46% -$262M
BSX icon
27
Boston Scientific
BSX
$73B
$316M 1.36%
4,109,157
-487,500
-11% -$35.7M
ADI icon
28
Analog Devices
ADI
$182B
$293M 1.26%
1,284,800
-253,190
-16% -$54M
ABNB icon
29
Airbnb
ABNB
$110B
$258M 1.11%
1,701,000
+92,780
+6% +$14.2M
AGIO icon
30
Agios Pharmaceuticals
AGIO
$1.98B
$244M 1.05%
5,654,502
+63,900
+1% +$2.31M
V icon
31
Visa
V
$693B
$216M 0.93%
821,886
+141,036
+21% +$38.7M
YMM icon
32
Full Truck Alliance
YMM
$9.1B
$208M 0.89%
25,850,303
-434,756
-2% -$3.7M
MA icon
33
Mastercard
MA
$509B
$204M 0.88%
462,771
-50,390
-10% -$23M
PTGX icon
34
Protagonist Therapeutics
PTGX
$9.99B
$202M 0.87%
5,840,773
+101,800
+2% +$2.98M
HCP
35
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$199M 0.85%
+5,905,000
New +$184M
HWM icon
36
Howmet Aerospace
HWM
$108B
$197M 0.85%
2,541,839
-868,920
-25% -$65.8M
SHW icon
37
Sherwin-Williams
SHW
$84.1B
$193M 0.83%
647,550
-106,280
-14% -$32.9M
AZN icon
38
AstraZeneca
AZN
$257B
$188M 0.81%
1,204,859
+475,000
+65% +$71.5M
BEAM icon
39
Beam Therapeutics
BEAM
$3.07B
$185M 0.8%
7,913,123
+3,401,370
+75% +$83.5M
LNTH icon
40
Lantheus
LNTH
$6.53B
$183M 0.79%
2,279,227
+796,000
+54% +$58.4M
MRNA icon
41
PUT
Moderna
MRNA
$57.9B
$154M 0.66%
+1,300,000
New +$165M
SRCL
42
DELISTED
Stericycle Inc
SRCL
$149M 0.64%
+2,560,000
New +$131M
CNC icon
43
Centene
CNC
$32.1B
$144M 0.62%
2,168,175
-439,700
-17% -$32M
MASI
44
DELISTED
Masimo
MASI
$141M 0.61%
1,119,563
-370,000
-25% -$48.7M
AMED
45
DELISTED
Amedisys
AMED
$120M 0.52%
1,308,500
+300,200
+30% +$27.9M
EDU icon
46
New Oriental
EDU
$8.88B
$114M 0.49%
1,469,590
+854,590
+139% +$69.6M
THC icon
47
Tenet Healthcare
THC
$22.6B
$91.5M 0.39%
687,442
+50,000
+8% +$6.02M
ANSS
48
DELISTED
Ansys
ANSS
$82M 0.35%
255,000
– –
LBPH
49
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$79.5M 0.34%
2,940,500
– –
BHVN icon
50
Biohaven
BHVN
$2.09B
$78M 0.33%
2,248,000
+1,449,000
+181% +$57.3M
1
2
3 4 5

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q2 2024 Portfolio in Review

As of Q2 2024, Thomas Steyer held 197 positions worth $23.3B, down 1.1% from $23.6B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Thomas Steyer withdrew a net $917M in Q2 2024, closing 30 positions and reducing 40 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $924M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Thomas Steyer opened a new position in Walt Disney worth $356M.

  • Thomas Steyer's largest Q2 2024 buy was Walt Disney: 3,582,168 shares worth $356M.
  • Thomas Steyer added most to Aon in Q2 2024, an estimated $368M increase.
  • Thomas Steyer's biggest Q2 2024 reduction was Alphabet (Google) Class C, cutting an estimated $262M.
  • Thomas Steyer fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $924M.
  • Thomas Steyer's ten largest holdings make up 48% of its $23.3B portfolio in Q2 2024.
  • Thomas Steyer opened 23 new positions and closed 30 in Q2 2024.
  • Thomas Steyer's portfolio value fell 1.1% quarter-over-quarter to $23.3B.

Based on Farallon Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.